These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16516224)

  • 1. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
    Pang KC; Wei JQ; Chen W
    J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular CD154 expression reflects antigen-specific CD8+ t cells but shows less sensitivity than intracellular cytokine and MHC tetramer staining.
    Han YW; Aleyas AG; George JA; Yoon HA; Lee JH; Kim BS; Eo SK
    J Microbiol Biotechnol; 2007 Dec; 17(12):1955-64. PubMed ID: 18167442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
    Laus R; Graddis TJ; Hakim I; Vidovic D
    Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
    O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
    Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance.
    Limmer A; Ohl J; Kurts C; Ljunggren HG; Reiss Y; Groettrup M; Momburg F; Arnold B; Knolle PA
    Nat Med; 2000 Dec; 6(12):1348-54. PubMed ID: 11100119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of Brefeldin A during dendritic cell isolation allows in vitro detection of cross-presented self-antigens.
    Benke D; Krüger T; Lang A; Hamilton-Williams EE; Kurts C
    J Immunol Methods; 2006 Mar; 310(1-2):12-9. PubMed ID: 16510151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.
    Stelekati E; Bahri R; D'Orlando O; Orinska Z; Mittrücker HW; Langenhaun R; Glatzel M; Bollinger A; Paus R; Bulfone-Paus S
    Immunity; 2009 Oct; 31(4):665-76. PubMed ID: 19818652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
    Serre K; Giraudo L; Siret C; Leserman L; Machy P
    Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
    Riond J; Elhmouzi J; Hudrisier D; Gairin JE
    Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self peptide/MHC class I complexes have a negligible effect on the response of some CD8+ T cells to foreign antigen.
    Spörri R; Reis e Sousa C
    Eur J Immunol; 2002 Nov; 32(11):3161-70. PubMed ID: 12555661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
    Klein I; Gassel HJ; Crispe IN
    Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
    J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.